These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37185161)

  • 1. Athletes With Attention-Deficit/Hyperactivity Disorder: Position Statement of the American Medical Society for Sports Medicine.
    Pujalte GGA; Narducci DM; Smith MS; King R; Logan K; Callender SS; Liebman CA; Kane SF; Israel MP; Wolf SF; Nuti R; Khodaee M
    Clin J Sport Med; 2023 May; 33(3):195-208. PubMed ID: 37185161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attention deficit hyperactivity disorder and the athlete: an American Medical Society for Sports Medicine position statement.
    Putukian M; Kreher JB; Coppel DB; Glazer JL; McKeag DB; White RD
    Clin J Sport Med; 2011 Sep; 21(5):392-401. PubMed ID: 21892014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Use of Stimulant Medication to Treat Attention-Deficit/Hyperactivity Disorder in Elite Athletes: A Performance and Health Perspective.
    Garner AA; Hansen AA; Baxley C; Ross MJ
    Sports Med; 2018 Mar; 48(3):507-512. PubMed ID: 29198023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considerations in the Care of Athletes With Attention Deficit Hyperactivity Disorder.
    Pujalte GGA; Maynard JR; Thurston MJ; Taylor WC; Chauhan M
    Clin J Sport Med; 2019 May; 29(3):245-256. PubMed ID: 29189334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations in the Use of Stimulants in Sport.
    Reardon CL; Factor RM
    Sports Med; 2016 May; 46(5):611-7. PubMed ID: 26712509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attention Deficit Hyperactivity Disorder in Athletes.
    Ciocca M
    Clin Sports Med; 2019 Oct; 38(4):545-554. PubMed ID: 31472765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Medical Society for Sports Medicine position statement: concussion in sport.
    Harmon KG; Drezner JA; Gammons M; Guskiewicz KM; Halstead M; Herring SA; Kutcher JS; Pana A; Putukian M; Roberts WO
    Br J Sports Med; 2013 Jan; 47(1):15-26. PubMed ID: 23243113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention deficit hyperactivity disorder, CNS stimulants and sport.
    Hickey G; Fricker P
    Sports Med; 1999 Jan; 27(1):11-21. PubMed ID: 10028130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of baseline and post-concussion ImPACT test scores in young athletes with stimulant-treated and untreated ADHD.
    Gardner RM; Yengo-Kahn A; Bonfield CM; Solomon GS
    Phys Sportsmed; 2017 Feb; 45(1):1-10. PubMed ID: 27736285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS; Genel M; Bezman RJ; Slanetz PJ
    JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attention-deficit/hyperactivity disorder in elite athletes: a narrative review.
    Han DH; McDuff D; Thompson D; Hitchcock ME; Reardon CL; Hainline B
    Br J Sports Med; 2019 Jun; 53(12):741-745. PubMed ID: 31097459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician perceptions of the use of medications for attention deficit hyperactivity disorder.
    Stockl KM; Hughes TE; Jarrar MA; Secnik K; Perwien AR
    J Manag Care Pharm; 2003; 9(5):416-23. PubMed ID: 14613439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention Deficit Hyperactivity Disorder: Unique Considerations in Athletes.
    Stewman CG; Liebman C; Fink L; Sandella B
    Sports Health; 2018; 10(1):40-46. PubMed ID: 29144831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mental health issues and psychological factors in athletes: detection, management, effect on performance and prevention: American Medical Society for Sports Medicine Position Statement-Executive Summary.
    Chang C; Putukian M; Aerni G; Diamond A; Hong G; Ingram Y; Reardon CL; Wolanin A
    Br J Sports Med; 2020 Feb; 54(4):216-220. PubMed ID: 31810972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of attention-deficit hyperactivity disorder in athletes.
    Kutcher JS
    Curr Sports Med Rep; 2011; 10(1):32-6. PubMed ID: 21228648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
    NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.
    Wigal SB
    CNS Drugs; 2009; 23 Suppl 1():21-31. PubMed ID: 19621975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of pharmaceutical therapy of ADHD (Attention-Deficit/Hyperactivity Disorder) in adults - health technology assessment.
    Benkert D; Krause KH; Wasem J; Aidelsburger P
    GMS Health Technol Assess; 2010 Sep; 6():Doc13. PubMed ID: 21289886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Text Message Intervention to Improve Adherence to Stimulants in Adults With Attention Deficit/Hyperactivity Disorder.
    Biederman J; Fried R; DiSalvo M; Woodworth KY; Biederman I; Noyes E; Faraone SV; Perlis RH
    J Clin Psychopharmacol; 2019; 39(4):351-356. PubMed ID: 31162154
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.